139 related articles for article (PubMed ID: 2847293)
21. Treatment of cytomegalovirus retinitis with ganciclovir.
Jabs DA; Newman C; De Bustros S; Polk BF
Ophthalmology; 1987 Jul; 94(7):824-30. PubMed ID: 2821465
[TBL] [Abstract][Full Text] [Related]
22. DHPG (Gancyclovir) improves survival in CMV pneumonia.
Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
[No Abstract] [Full Text] [Related]
23. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
[No Abstract] [Full Text] [Related]
24. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
[TBL] [Abstract][Full Text] [Related]
25. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
[TBL] [Abstract][Full Text] [Related]
26. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
[No Abstract] [Full Text] [Related]
27. Treatment and prophylaxis of cytomegalovirus disease.
Levinson ML; Jacobson PA
Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
[TBL] [Abstract][Full Text] [Related]
28. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.
Shepp DH; Dandliker PS; de Miranda P; Burnette TC; Cederberg DM; Kirk LE; Meyers JD
Ann Intern Med; 1985 Sep; 103(3):368-73. PubMed ID: 2992333
[TBL] [Abstract][Full Text] [Related]
29. Treatment of cytomegalovirus infection after renal transplantation: experience from a single center in China.
Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Xiang HL; Hou J; Tian XH; Zheng J; Ding CG; Fan P; Liu HB
Ann Transplant; 2013 Mar; 18():125-35. PubMed ID: 23792512
[TBL] [Abstract][Full Text] [Related]
30. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
31. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
Ho WG; Winston DJ; Champlin RE
Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
[No Abstract] [Full Text] [Related]
32. Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS.
Laskin OL; Stahl-Bayliss CM; Kalman CM; Rosecan LR
J Infect Dis; 1987 Feb; 155(2):323-7. PubMed ID: 3027195
[No Abstract] [Full Text] [Related]
33. Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis.
Jacobson MA; O'Donnell JJ; Brodie HR; Wofsy C; Mills J
J Med Virol; 1988 Jul; 25(3):339-49. PubMed ID: 2844981
[TBL] [Abstract][Full Text] [Related]
34. Ganciclovir.
Med Lett Drugs Ther; 1989 Aug; 31(799):79-80. PubMed ID: 2549352
[No Abstract] [Full Text] [Related]
35. Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.
Keay S; Bissett J; Merigan TC
J Infect Dis; 1987 Dec; 156(6):1016-21. PubMed ID: 2824621
[No Abstract] [Full Text] [Related]
36. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
37. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
[TBL] [Abstract][Full Text] [Related]
38. Antiviral therapy with ganciclovir for cytomegalovirus retinitis and bilateral exudative retinal detachments in an immunocompromised child.
Rosecan LR; Laskin OL; Kalman CM; Haik BG; Ellsworth RM
Ophthalmology; 1986 Nov; 93(11):1401-7. PubMed ID: 3027642
[TBL] [Abstract][Full Text] [Related]
39. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.
Harbison MA; De Girolami PC; Jenkins RL; Hammer SM
Transplantation; 1988 Jul; 46(1):82-8. PubMed ID: 2839916
[TBL] [Abstract][Full Text] [Related]
40. Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.
Selby P; Powles RL; Jameson B; Stolle K; Tryhorn Y; Stern H
Lancet; 1986 Jun; 1(8494):1377-8. PubMed ID: 2872484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
